Dipna Pharmachem share price
BSE: 543594Pharmaceuticals & BiotechnologySmall Cap
Last close ₹3.89down ₹0.04 (1.02%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹3.93.
52-week range of traded prices to 23 Oct 2026
₹3.89Low, 8 Oct 2026₹20.50High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹10 Cr3,953rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 18,000
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Mar 2026Filed 2 Jul
- Revenue
- ₹2.02 Cr
- Net profit
- ₹0.18 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 8.8%
Revenue by year
Peak revenue ₹164 Cr, year to Mar 2024
Net profit by year, a loss in red
| ₹ crore | Mar 2026Filed 2 Jul |
|---|---|
| Revenue | 2.02 |
| Net profit | 0.18 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 8.8% |
Standalone. The quarter to Mar 2026, the first on record; the half years before it are below.
| ₹ crore | Sep 2024Filed 21 Dec | Mar 2025Filed 7 Jul | Sep 2025Filed 26 Nov |
|---|---|---|---|
| Revenue | 90.6 | 34.3 | 72.3 |
| Net profit | 0.3 | 0.6 | 1.4 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 0.4% | 1.9% | 2.0% |
Standalone. The half years in the same span that the quarters on record do not fully cover.
Business segments
Share of revenue, year to Mar 2026, standalone.Segment revenue and profit
- Steel SegmentSteel Segment, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹70.9 Cr54.9%
- Chemicals SegmentChemicals Segment, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹58.2 Cr45.1%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −43.9% | +143.9% | −77.0% | 0.0% |
| 3 years | −13.9% | +9.6% | −21.4% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Dipna Pharmachem in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
Dipna Pharmachem is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mono PharmacareMONOPHARMA | 15 | 42.4 | 0.5 | – | −1.6% | −88.3% | 1.1% | – | 0.00% |
 Beryl DrugsBERLDRG | 13 | 20.1 | 1.3 | 8.1 | +8.3% | +169.1% | 6.4% | 3.1% | 0.00% |
 Unjha FormulationsUNJHAFOR | 12 | 26.2 | 3.2 | 14.6 | +13.0% | +386.7% | 13.5% | 15.2% | 0.00% |
 Ortin GlobalORTINGLOBE | 10 | – | 8.4 | – | −58.3% | – | −56.2% | −52.2% | 0.00% |
 Adline Chem LabADLINE | 9 | – | – | – | – | – | – | −685.2% | 0.00% |
 Brawn BiotechBRAWN | 8 | 8.9 | 1.8 | – | +13.6% | – | 22.3% | −12.6% | 0.00% |
 Vivanza BiosciencesVIVANZA | 6 | 14.1 | 1.5 | 32.8 | +735.0% | – | 10.9% | 3.3% | 0.00% |
 Decipher LabsDECIPHER | 5 | – | 0.6 | – | −25.2% | – | – | −31.5% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
23 Oct · Management
Jul 2026
2 Jul · Results
Dipna Pharmachem share price by year
Each calendar year to 2025.Dipna Pharmachem share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 16.90 | +17.3% | 25.79 | 11.74 |
| 2024 | 14.41 | +35.3% | 16.83 | 6.68 |
| 2023 | 10.65 | −47.8% | 28.64 | 10.65 |
| 2022 | 20.40 | – | 33.40 | 19.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 8 Sep 2022.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 3.90 | 3.90 | 3.89 | 3.89 | 3.90 | 18,000 |
| 22 Oct 2026 | 4.05 | 4.05 | 3.90 | 3.93 | 3.94 | 30,000 |
| 21 Oct 2026 | 4.05 | 4.05 | 4.05 | 4.05 | 4.05 | 6,000 |
| 19 Oct 2026 | 4.06 | 4.09 | 4.05 | 4.06 | 4.07 | 12,000 |
| 16 Oct 2026 | 4.09 | 4.16 | 3.97 | 3.97 | 4.09 | 27,000 |
| 15 Oct 2026 | 4.04 | 4.09 | 4.04 | 4.05 | 4.05 | 21,000 |
| 14 Oct 2026 | 4.17 | 4.17 | 4.02 | 4.04 | 4.06 | 1,08,000 |
| 13 Oct 2026 | 4.36 | 4.54 | 4.06 | 4.17 | 4.23 | 84,000 |
| 12 Oct 2026 | 4.02 | 4.34 | 4.02 | 4.34 | 4.26 | 69,000 |
| 9 Oct 2026 | 4.15 | 4.25 | 3.89 | 3.95 | 4.01 | 75,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 12 Feb 2024 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.
Company details
- Legal name
- DIPNA PHARMACHEM LIMITED
- BSE code
- 543594
- ISIN
- INE0MC401013
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Sep 2022
- Face value
- ₹10
- CIN
- L24100GJ2011PLC066400
- Corporate identity number, the registrar of companies' code for it